ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Biomerica Inc

Biomerica Inc (BMRA)

0.958
-0.072
( -6.99% )
Updated: 13:10:34

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.958
Bid
0.955
Ask
0.9598
Volume
1,216,524
0.9102 Day's Range 1.05
0.2415 52 Week Range 1.35
Market Cap
Previous Close
1.03
Open
1.00
Last Trade
1
@
0.9607
Last Trade Time
13:10:24
Financial Volume
$ 1,190,585
VWAP
0.978678
Average Volume (3m)
9,266,699
Shares Outstanding
18,336,994
Dividend Yield
-
PE Ratio
-2.98
Earnings Per Share (EPS)
-0.33
Revenue
5.42M
Net Profit
-5.98M

About Biomerica Inc

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain es... Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Headquarters
Wilmington, Delaware, USA
Founded
-
Biomerica Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker BMRA. The last closing price for Biomerica was $1.03. Over the last year, Biomerica shares have traded in a share price range of $ 0.2415 to $ 1.35.

Biomerica currently has 18,336,994 shares outstanding. The market capitalization of Biomerica is $18.89 million. Biomerica has a price to earnings ratio (PE ratio) of -2.98.

BMRA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.21328.59060402680.7451.10.6819189260.91675599CS
40.393269.61756373940.56481.10.42917179340.71872152CS
120.6554216.5895571710.30261.270.2692666990.6700699CS
260.6468207.8406169670.31121.270.2641997550.65322374CS
52-0.102-9.622641509431.061.350.241521664880.65119352CS
156-3.592-78.94505494514.555.250.24158894230.90442172CS
260-1.842-65.78571428572.823.390.24158245263.23644809CS

BMRA - Frequently Asked Questions (FAQ)

What is the current Biomerica share price?
The current share price of Biomerica is $ 0.958
How many Biomerica shares are in issue?
Biomerica has 18,336,994 shares in issue
What is the market cap of Biomerica?
The market capitalisation of Biomerica is USD 18.89M
What is the 1 year trading range for Biomerica share price?
Biomerica has traded in the range of $ 0.2415 to $ 1.35 during the past year
What is the PE ratio of Biomerica?
The price to earnings ratio of Biomerica is -2.98
What is the cash to sales ratio of Biomerica?
The cash to sales ratio of Biomerica is 3.28
What is the reporting currency for Biomerica?
Biomerica reports financial results in USD
What is the latest annual turnover for Biomerica?
The latest annual turnover of Biomerica is USD 5.42M
What is the latest annual profit for Biomerica?
The latest annual profit of Biomerica is USD -5.98M
What is the registered address of Biomerica?
The registered address for Biomerica is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Biomerica website address?
The website address for Biomerica is www.biomerica.com
Which industry sector does Biomerica operate in?
Biomerica operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
$ 8.23
(102.71%)
85M
LYTLytus Technologies Holdings PTV Ltd
$ 0.3758
(68.82%)
195.68M
ATGLAlpha Technology Group Limited
$ 50.23
(64.69%)
204.43k
SINTSiNtx Technologies Inc
$ 4.2901
(52.13%)
66.39M
RSLSReShape Lifesciences Inc
$ 1.51
(39.81%)
34.56M
NKLANikola Corporation
$ 0.4407
(-42.46%)
93.55M
BPTHBio Path Holdings Inc
$ 0.131
(-37.62%)
1.77M
CNSPCNS Pharmaceuticals Inc
$ 0.0945
(-33.68%)
66.48M
MULNMullen Automotive Inc
$ 7.10
(-28.28%)
722.77k
BMBLBumble Inc
$ 5.84
(-27.90%)
15.95M
ADTXAditxt Inc
$ 0.1326
(20.55%)
514.87M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0673
(23.49%)
412.74M
LYTLytus Technologies Holdings PTV Ltd
$ 0.376
(68.91%)
195.68M
SMCISuper Micro Computer Inc
$ 64.42
(15.45%)
182.14M
INTCIntel Corporation
$ 25.7535
(-5.97%)
103.99M

BMRA Discussion

View Posts
RAlbert RAlbert 12 hours ago
$$5 is not impossible
👍️0
harry crumb harry crumb 18 hours ago
You bet👍
👍️0
Invest-in-America Invest-in-America 4 days ago
BMRA: Monster THANKS, Admiral H-C, Dude --- for the heads-up, Bro!!! (LOVE this stuff!!!)
👍️0
harry crumb harry crumb 5 days ago
We bought this today, loaded! This company may soar to the moon! $$$$$$
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA: Looks good!!
👍️0
RAlbert RAlbert 1 month ago
Holding tight after market. Low issues shared could potentially be a 10 bagger
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA: Heck, anything affiliated with the UAE over there is gonna get big attention!!
👍️0
knrorrel knrorrel 1 month ago
great dip now 0.65
👍️0
knrorrel knrorrel 1 month ago
news was good today
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA: Hey, K-N-R, it sure looks that way!!
👍️0
knrorrel knrorrel 1 month ago
0.72 add.
👍️0
knrorrel knrorrel 1 month ago
bounce time
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA: WOW!! Rough ride this Wall Street morning, Dude!! (That's ME, below, tryin' to keep pace with yah, Boss!!)

👍️0
tw0122 tw0122 1 month ago
Nice volume looks liken.67 will hold for next round but Caution as always 
👍️0
tw0122 tw0122 1 month ago
See if it holds at least .67 can do another round doesn't hold then wait for .50 to .53
👍️0
glenn1919 glenn1919 1 month ago
bmra....................................https://stockcharts.com/h-sc/ui?s=bmra&p=W&b=5&g=0&id=p86431144783
👍 1
firebag1 firebag1 1 month ago
pretty good news release id say
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA: But ya banked some coin, Bro!! (I've been takin' YOUR sage advice for months now, on HOW to play this Wall Street CASINO.)

I still DO like their NEWS here today. (They got that HALF-MILE-HIGH building over there!!)
https://en.wikipedia.org/wiki/Burj_Khalifa
////////////////////////////////////////////////////////////////////////////////////////////
👍️0
tw0122 tw0122 1 month ago
Took 80% off $1.15- $1.18 unless followed through will be all out average .88 so $.95 out 
👍️0
elks elks 1 month ago
give us 2
👍️0
knrorrel knrorrel 1 month ago
holy shi_ ..... LET'S GOOOOO
👍️0
tw0122 tw0122 1 month ago
looking good breakout of $1.29 solid and off to $2 land should be a done deal
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA; Excuse me for a minute, my PROSTATE wants to take a PISS again!!!! (And my "Big-Gulp-Coffee" from 7/11 15-minutes ago didn't help it EITHER!!!)
👍️0
knrorrel knrorrel 1 month ago
coming $2+ today still ?
👍️0
knrorrel knrorrel 1 month ago
under fire
👍️0
subslover subslover 1 month ago
It looks as though it will open back up in the $1.32 range
👍️0
tw0122 tw0122 1 month ago
$1.18 halt 
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA: My BLADDER woke me up!!! (Who says that???)
👍️0
tw0122 tw0122 1 month ago
Yes lots of revenues potential immediately see a resistance zone all the way up $2.75 to $2.96 if they really let the goose loose. See what happens US contracts on the way 
👍️0
subslover subslover 1 month ago
Insiders loaded back on 12/17 with millions of shares @ $0.31. They knew this was gonna happen. https://www.otcmarkets.com/stock/BMRA/disclosure
👍️0
subslover subslover 1 month ago
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer
- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer

- Prostate Cancer: The Second Most Common Cancer in Men Globally

IRVINE, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of innovative diagnostic solutions, is proud to announce that its Fortel® Prostate Specific Antigen (PSA) Screening Test has received approval from the United Arab Emirates Ministry of Health and Prevention (MOHAP).

The Fortel® PSA Screening Test is a user-friendly diagnostic tool that provides accurate results in just 10 minutes using a simple finger-prick blood sample. By measuring elevated PSA levels, a recognized early marker of prostate disease, the test can enable early detection of prostate cancer and other prostate-related conditions. This rapid and accessible approach aims to enhance proactive health management, reduce the burden on healthcare systems, and improve patient outcomes.

Strategic Expansion in the Middle East

This milestone approval is part of Biomerica’s strategic initiative to expand its footprint in the Middle East, where prostate cancer is increasingly recognized as a critical public health concern. Building on its success in the region with the EZ Detect Colon Disease At-Home Screening Test, which received government insurance reimbursement in Dubai, Biomerica is working to replicating this achievement with the Fortel® PSA test. The Company has established partnerships with leading distributors and secured key regulatory approvals to make early cancer detection more accessible to patients in the region.

Proven Performance

The Fortel® PSA test has demonstrated outstanding performance in rigorous evaluations:

A study reported 100% sensitivity, 95% specificity, and 97.5% accuracy, aligning with laboratory reference methods.
Research conducted at the Faculty of Medicine, Ain Shams University in Egypt, further validated the test’s effectiveness, achieving 97.2% sensitivity, 96.2% specificity, and 96.7% accuracy.
These results highlight the Fortel® PSA test as a reliable and efficient tool for early detection.

The Growing Global and Regional Impact of Prostate Cancer

Prostate cancer is the second most common cancer among men worldwide, with 1.4 million new cases diagnosed and 375,000 deaths reported globally in 20201. Alarmingly, one new case is diagnosed every two minutes2. While extensive research and advancements in early detection have been made in Europe and North America, prostate cancer has become increasingly recognized as a significant public health challenge in the Middle East. The disease varies in prevalence and severity across different regions, age groups, ethnicities, and races and there remains a gap in comprehensive studies within the Middle East3.

Looking Ahead: Expanding Access to Life-Saving Diagnostics

Biomerica is reinforcing its commitment to expanding access to innovative diagnostic solutions in the Middle East. The company’s vision remains focused on providing affordable, accurate, and accessible tools to aid in the early detection and treatment of critical diseases like prostate cancer.

https://uroweb.org/guidelines/prostate-cancer/chapter/epidemiology-and-aetiology%E2%80%8B
https://zerocancer.org/about-prostate-cancer/facts-statistics
Mutlay Sayan et al. Prostate Cancer Awareness in the Middle East: A Cross-Sectional International Study. JCO Glob Oncol 10, e2400171(2024).
About Biomerica (NASDAQ: BMRA)

Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Biomerica) contains statements that are forward-looking, such as statements relating to the Company’s current and future sales, revenues, overhead, expenses, cost of goods, operations and earnings, efficacy of the Company’s products and tests, FDA and/or international regulatory authorization for the Company’s products to be marketed and sold, including the Fortel PSA product, and the Company’s other current and future products, the possible expansion in to other markets, uniqueness of the Company’s products, accuracy of the Company’s tests and products, pricing of the Company’s test kits, domestic and/or international market adoption and acceptance and demand for the Company’s products, future use of the Company's products by physicians to treat their patients, potential revenues from the sale of current or future products. Such forward-looking information involves impo
👍️0
tw0122 tw0122 1 month ago
$1.07 start cashing out some
👍️0
tw0122 tw0122 1 month ago
97 + 177%
👍️0
tw0122 tw0122 1 month ago
Yes my bad zone it's in now is .74 to $1.29 let the goose loose.
👍️0
tw0122 tw0122 1 month ago
.83 resistance see if .53 to .57 new support 
👍️0
tw0122 tw0122 1 month ago
Early morning jackpot prostate news .80 +'120%
👍️0
Invest-in-America Invest-in-America 1 month ago
BMRA: And MONSTER news over in the ARABIC world for this PUPPY!!!
👍️0
glenn1919 glenn1919 1 month ago
BMRA.............https://stockcharts.com/h-sc/ui?s=BMRA&p=W&b=5&g=0&id=p86431144783
👍️0
ErnieBilco ErnieBilco 2 months ago
They vote on a RS next Friday the 13th - not a good omen IMO
👍️0
glenn1919 glenn1919 3 months ago
BMRA...................https://stockcharts.com/h-sc/ui?s=BMRA&p=W&b=5&g=0&id=p86431144783
👍️0
BurgerKing82 BurgerKing82 3 months ago
Most volume in a year .. potential here?
👍️0
glenn1919 glenn1919 3 months ago
BMRA...................https://stockcharts.com/h-sc/ui?s=BMRA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
BMRA....................https://stockcharts.com/h-sc/ui?s=BMRA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 months ago
BMRA...........................................https://stockcharts.com/h-sc/ui?s=BMRA&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 6 months ago
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer
👍️0
Awl416 Awl416 6 months ago
Uh oh
👍️0
Awl416 Awl416 9 months ago
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
👍️0
Awl416 Awl416 10 months ago
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
👍️0
glenn1919 glenn1919 12 months ago
BMRA.................................https://stockcharts.com/h-sc/ui?s=BMRA&p=W&b=5&g=0&id=p86431144783
👍️0
BurgerKing82 BurgerKing82 1 year ago
With the right news...she could pop...
👍️0

Your Recent History

Delayed Upgrade Clock